시장보고서
상품코드
1429601

세계의 의약품 시장 보고서(2024년)

Pharmaceutical Drugs Global Market Report 2024

발행일: | 리서치사: The Business Research Company | 페이지 정보: 영문 400 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

제약 시장 규모는 향후 몇 년동안 빠르게 성장할 것으로 예상됩니다. 2028년에는 13.4%의 연평균 복합 성장률(CAGR)로 2조 929억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간의 확대는 정부 지원 증가, 의료 접근성 증가, 투자 증가, 노인 인구의 급속한 증가, 의료비 지출 급증, 예방접종 및 백신 접종에 대한 인식 증가에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 신약 개발에 바이오마커 사용, 차세대 바이오의약품 개발에 대한 관심 증가, 개인 맞춤형 의료에 대한 집중, 신약 개발을 위한 인공지능(AI)에 대한 투자, 치료제의 병용요법 채택 등이 있습니다. 호흡기 질환, 의약품 연구개발 강화를 위한 웨어러블 기업과의 제휴, 의약품 제조에 3D 프린팅 기술 활용, 약물 전달을 개선하기 위한 마이크로니들 정제 개발, mRNA 기술을 이용한 백신 개발의 발전 등이 있습니다.

좌식 업무 증가, 바쁜 생활방식 증가, 소비자 취향의 진화는 전 세계 질병 상황, 특히 암, 당뇨병, 심혈관 질환과 같은 비감염성 질환의 확산에 영향을 미치고 있습니다. 장시간 노동, 신체 활동 감소, 건강에 해로운 식습관 등의 요인은 당뇨병과 같은 만성 질환에 큰 영향을 미칩니다. 세계보건기구(WHO)에 따르면, 비감염성 질환(NCD)으로 인한 연간 사망자 수는 4,100만 명으로 전 세계 사망률의 74%를 차지합니다. 이러한 추세는 당뇨병과 같은 증상을 치료하기 위한 생물학적 제제에 대한 수요가 증가하고 있음을 뒷받침합니다. 이러한 요인으로 인해 전 세계 환자 인구가 증가할 것으로 예상되며, 이는 예측 기간 동안 의약품 시장의 성장을 가속할 것으로 예상됩니다.

희귀질환의 발생 증가는 향후 의약품 시장을 견인할 것으로 예상됩니다. 희귀질환은 일반적인 건강 문제에 비해 유병률이 낮고 인구의 일부에만 영향을 미치는 것이 특징입니다. 의약품은 이러한 질병을 관리하고, 잠재적인 치료법을 쉽게 식별하고, 심각한 부작용을 수반하는 불필요한 치료를 방지하고, 효과적인 치료 접근법에 기여하는 데 중요한 역할을 합니다. 예를 들어, 2021년 2월 기준 국제골다공증재단(IOF)은 전 세계적으로 3억 명 이상이 희귀질환을 앓고 있으며, 이는 전 세계 인구의 3.5%-5.9%에 해당한다고 보고했습니다. 또한, 호주에 본사를 둔 디지털 헬스 기업 헬스매치(Health Match)는 2022년 11월 미국과 유럽에서 인구 10만 명당 60-80명의 발병률을 보이는 약 150개의 희귀 신장 질환을 확인했습니다. 따라서 희귀질환의 발생률 증가는 의약품 시장 성장의 촉매제 역할을 할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 제품/서비스 분석 - 제품/서비스 예

  • 의약품 공급망 분석
    • 의약품 리소스
    • 의약품 제조업체
    • 의약품 유통업체와 소매업체
    • 의약품 최종사용자
  • 의약품 고객 정보

제4장 시장 동향과 전략

제5장 거시경제 시나리오

  • 고인플레이션이 시장에 미치는 영향
  • 우크라이나·러시아 전쟁이 시장에 미치는 영향
  • 시장에 대한 COVID-19의 영향

제6장 세계 시장 규모와 성장

  • 세계의 의약품 시장 성장 촉진요인과 억제요인
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 의약품 시장 규모 실적과 성장, 2018-2023년
  • 세계의 의약품 시장 규모와 성장 예측, 2023-2028년, 2033년

제7장 시장 세분화

  • 세계의 의약품 시장, 유형별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 심장혈관 치료제
  • 피부과 치료제
  • 위장약
  • 생식기 비뇨기 치료제
  • 혈액 내과 치료제
  • 항감염증약
  • 대사장애증 치료제
  • 근골격계 질환 치료제
  • 중추신경계 치료제
  • 세계의 의약품 시장, 의약품 분류별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 브랜드 의약품
  • 제네릭 의약품
  • 세계의 의약품 시장, 투여 경로별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 경구
  • 비경구
  • 기타
  • 세계의 의약품 시장, 구입 방법별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 처방약
  • 시판약
  • 세계의 의약품 시장, 유통 채널별 세분화, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 병원 약국
  • 소매 약국/드럭스토어
  • 기타

제8장 지역 및 국가별 분석

  • 세계의 의약품 시장, 지역별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년
  • 세계의 의약품 시장, 국가별, 실적과 예측, 2018-2023년, 2023-2028년, 2033년

제9장 아시아태평양 시장

제10장 중국 시장

제11장 인도 시장

제12장 일본 시장

제13장 호주 시장

제14장 인도네시아 시장

제15장 한국 시장

제16장 방글라데시 시장

제17장 태국 시장

제18장 베트남 시장

제19장 말레이시아 시장

제20장 싱가포르 시장

제21장 필리핀 시장

제22장 홍콩 시장

제23장 뉴질랜드 시장

제24장 서유럽 시장

제25장 영국 시장

제26장 독일 시장

제27장 프랑스 시장

제28장 이탈리아 시장

제29장 스페인 시장

제30장 오스트리아 시장

제31장 벨기에 시장

제32장 덴마크 시장

제33장 핀란드 시장

제34장 아일랜드 시장

제35장 네덜란드 시장

제36장 노르웨이 시장

제37장 포르투갈 시장

제38장 스웨덴 시장

제39장 스위스 시장

제40장 동유럽 시장

제41장 러시아 시장

제42장 체코 시장

제43장 폴란드 시장

제44장 루마니아 시장

제45장 우크라이나 시장

제46장 북미 시장

제47장 미국 시장

제48장 캐나다 시장

제49장 멕시코 시장

제50장 남미 시장

제51장 브라질 시장

제52장 칠레 시장

제53장 아르헨티나 시장

제54장 콜롬비아 시장

제55장 페루 시장

제56장 중동 시장

제57장 사우디아라비아 시장

제58장 이스라엘 시장

제59장 이란 시장

제60장 터키 시장

제61장 아랍에미리트 시장

제62장 아프리카 시장

제63장 이집트 시장

제64장 나이지리아 시장

제65장 남아프리카공화국 시장

제66장 경쟁 구도와 기업 개요

  • 의약품 시장 경쟁 구도
  • 의약품 시장 기업 개요
    • Pfizer Inc.
    • AbbVie
    • Johnson &Johnson
    • Merck &Co
    • Sanofi SA

제67장 기타 주요 기업과 혁신 기업

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Bristol-Myers Squibb
  • AstraZeneca
  • GlaxosmithKline
  • Shanghai Pharmaceutical Drugs
  • Shanghai Fosun Pharmaceutical
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • China National Pharmaceutical Group Co., Ltd.(Sinopharm)
  • Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd
  • Hanmi Pharmaceutical
  • Cipla Limited

제68장 경쟁 벤치마킹

제69장 경쟁 대시보드

제70장 주요 인수합병(M&A)

제71장 향후 전망과 잠재성 분석

제72장 부록

LSH 24.03.08

A pharmaceutical drug is a substance designed for the treatment, prevention, or alleviation of an illness, condition, or its symptoms. These substances can be administered through various methods, including oral consumption, skin patches, injections, or inhalation. Notable pharmaceuticals derived from natural sources encompass vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics.

The primary categories of pharmaceutical drugs cover a wide spectrum, including cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are specifically tailored to address medical conditions related to the heart or circulatory system, such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. These drugs can be administered through various routes, including oral and parenteral methods, and are categorized as branded or generic drugs. The acquisition of pharmaceutical drugs can occur through prescription-based or over-the-counter channels, with distribution taking place through hospital pharmacies, retail pharmacies/drug stores, and other outlets.

The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical drugs market size has grown strongly in recent years. It will grow from $1199.86 billion in 2023 to $1267.05 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion in the historical period can be ascribed to an upswing in healthcare awareness, a heightened prevalence of respiratory diseases, shifts in lifestyles, a surge in pharmaceutical research and development (R&D) expenditure, a growing aging population, a rise in the number of surgical procedures, robust economic growth in emerging markets, and an increased number of approvals for hematology/oncology (cancer) drugs.

The pharmaceutical drugs market size is expected to see rapid growth in the next few years. It will grow to $2092.95 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The expansion in the forecast period can be attributed to growing government support, an increase in healthcare access, a rise in investments, rapid growth in the elderly population, an upsurge in healthcare expenditure, and heightened awareness of immunization and vaccination. Key trends in the forecast period include the use of biomarkers for drug development, an increased focus on next-generation biologics development, a heightened emphasis on personalized medicine, investments in artificial intelligence (AI) for drug discovery, the adoption of combination drug therapy for respiratory diseases, partnerships with wearables companies to enhance drug research and development, the utilization of 3D printing technology in drug manufacturing, the development of microneedle pills for improved drug delivery, and advancements in vaccine development using mRNA technology.

The increase in sedentary jobs, busy lifestyles, and evolving consumer preferences is impacting the global disease landscape, particularly the prevalence of non-communicable diseases such as cancer, diabetes, and cardiovascular conditions. Factors such as prolonged working hours, reduced physical activity, and unhealthy dietary habits contribute significantly to chronic diseases such as diabetes. According to the World Health Organization, noncommunicable diseases (NCDs) account for 41 million deaths annually, representing 74% of global mortality. This trend underscores the growing demand for biologic drugs to address conditions such as diabetes. These factors are anticipated to expand the global patient population, thereby fostering growth in the pharmaceutical drug market throughout the forecast period.

The escalating occurrence of rare diseases is expected to drive the pharmaceutical drug market in the future. Rare diseases, characterized by low prevalence in comparison to more common health issues, affect only a small percentage of the population. Pharmaceutical drugs play a crucial role in managing these diseases, facilitating the identification of potential therapeutics, and preventing unnecessary treatments with severe side effects, contributing to effective treatment approaches. For instance, as of February 2021, the International Osteoporosis Foundation (IOF) reported that over 300 million people worldwide are affected by rare diseases, constituting 3.5% to 5.9% of the global population. Additionally, in November 2022, Health Match, an Australia-based digital health company, highlighted approximately 150 rare kidney diseases with high prevalence rates, ranging from 60 to 80 incidences per 100,000 people in America and Europe. Hence, the increasing incidence of rare diseases acts as a catalyst for the pharmaceutical drug market's growth.

Leading companies in the pharmaceutical drug market are introducing innovative medications such as Sohonos (palovarotene) capsules to establish a competitive advantage. Sohonos, a retinoid, is designed to reduce the volume of new heterotopic ossification in individuals with fibrodysplasia ossificans progressiva (FOP). For instance, in August 2023, Ipsen Biopharmaceuticals, Inc., a France-based biopharmaceutical company, unveiled Sohonos (palovarotene). This retinoid is indicated for minimizing the volume of new heterotopic ossification in adults and pediatric patients (8 years and older for females, 10 years and older for males) with FOP-a rare genetic disorder characterized by abnormal bone development in areas not typically containing bone, leading to limited movement, deformities, and severe disability.

An emerging trend in the dermatology drugs market is the early Rx-to-OTC switch, where products transition from prescription to non-prescription status. Traditionally, this shift occurred near the drug's patent expiry or afterward. However, forward-thinking companies are now opting for early Rx-to-OTC switches well in advance of patent expiry to capitalize on market opportunities and recover product-related expenses. This strategy offers additional benefits to manufacturers. For instance, in 2020, the FDA approved the switch of three prescription drugs to OTC status, including Voltaren for arthritis pain and olopatadine hydrochloride 0.1% and 0.2% (Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes caused by pollen, ragweed, and grass.

Major companies operating in the pharmaceutical drugs market report are Pfizer Inc., AbbVie, Johnson & Johnson, Merck & Co, Sanofi S.A., F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, AstraZeneca, GlaxosmithKline, Shanghai Pharmaceutical Drugs, Shanghai Fosun Pharmaceutical, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd. (Sinopharm), Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd., Kalbe Farma, Hyphens Pharma, Adjuvanz Technology Pte Ltd., Alliance Pharm Pte Ltd., Teva UK Limited, Abbott Laboratories, Vectura Group, Boehringer Ingelheim, Mylan, Zentiva, Apotex, Gilead Sciences, Bayer, Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Ache, Mantecorp Farmasa, Libbs, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Julphar, Neopharma, Johnson & Johnson, Eurolab, Aspen.

North America was the largest region in the pharmaceutical drugs market in 2023. Middle East is expected to be the fasted growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical drugs market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1)By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorder Drugs; Musculoskeletal Disorder Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Disease Drugs; Vaccine And Therapeutic Nutrients; Minerals
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
  • 3) By Drug Classification: Branded Drugs; Generic Drugs
  • 4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs; Prescription-Based Drugs
  • Sub segments: Anti-Hypertensive Drugs; Hypolipidemic; Anti-Thrombotic; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs); Acne; Dermatitis; Psoriasis; Other Drugs For Dermatology Diseases; Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrheals; Hormonal Contraceptives; Drugs For Benign Prostatic Hyperplasia; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence; Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics; Blood Products And Anemia; Other Blood Disorder Drugs; Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal); Anti-Diabetic Drugs; Anti-Thyroid Drugs; Anti-Obesity; Others; Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs; Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Alzheimer; Other CNS Drugs; Drugs For Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmology Drugs; Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations; Therapeutic Vaccines And Preventive Vaccines; Electrolytes And Minerals; Vitamins
  • Companies Mentioned: Pfizer Inc.; AbbVie; Johnson & Johnson; Merck & Co; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Drugs Market Characteristics

3. Pharmaceutical Drugs Product/Service Analysis -Product/Service Examples

  • 3.1. Pharmaceutical Drugs Supply Chain Analysis
    • 3.1.1. Pharmaceutical Drugs Resources
    • 3.1.2. Pharmaceutical Drugs Manufacturers
    • 3.1.3. Pharmaceutical Drugs Distributors and Retailers
    • 3.1.4. Pharmaceutical Drugs End Users
  • 3.2. Pharmaceutical Drugs Customer Information

4. Pharmaceutical Drugs Market Trends And Strategies

5. Pharmaceutical Drugs Market - Macro Economic Scenario

  • 5.1. Impact Of High Inflation On The Market
  • 5.2. Ukraine-Russia War Impact On The Market
  • 5.3. COVID-19 Impact On The Market

6. Global Pharmaceutical Drugs Market Size and Growth

  • 6.1. Global Pharmaceutical Drugs Market Drivers and Restraints
    • 6.1.1. Drivers Of The Market
    • 6.1.2. Restraints Of The Market
  • 6.2. Global Pharmaceutical Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 6.3. Global Pharmaceutical Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

7. Pharmaceutical Drugs Market Segmentation

  • 7.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorders Drugs
  • Musculoskeletal Disorders Drugs
  • Central Nervous System Drugs
  • 7.2. Global Pharmaceutical Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 7.3. Global Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administration
  • 7.4. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
  • 7.5. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Other Distribution Channels

8. Pharmaceutical Drugs Market Regional And Country Analysis

  • 8.1. Global Pharmaceutical Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.2. Global Pharmaceutical Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. Asia-Pacific Pharmaceutical Drugs Market

  • 9.1. Asia-Pacific Pharmaceutical Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 9.2. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 9.3. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 9.4. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10. China Pharmaceutical Drugs Market

  • 10.1. China Pharmaceutical Drugs Market Overview
  • 10.2. China Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 10.3. China Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 10.4. China Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

11. India Pharmaceutical Drugs Market

  • 11.1. India Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. India Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. India Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Japan Pharmaceutical Drugs Market

  • 12.1. Japan Pharmaceutical Drugs Market Overview
  • 12.2. Japan Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Japan Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.4. Japan Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Australia Pharmaceutical Drugs Market

  • 13.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Australia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Australia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. Indonesia Pharmaceutical Drugs Market

  • 14.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. Indonesia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. Indonesia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. South Korea Pharmaceutical Drugs Market

  • 15.1. South Korea Pharmaceutical Drugs Market Overview
  • 15.2. South Korea Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. South Korea Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. South Korea Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. Bangladesh Pharmaceutical Drugs Market

  • 16.1. Bangladesh, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 16.2. Bangladesh, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

17. Thailand Pharmaceutical Drugs Market

  • 17.1. Thailand, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 17.2. Thailand, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

18. Vietnam Pharmaceutical Drugs Market

  • 18.1. Vietnam, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 18.2. Vietnam, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

19. Malaysia Pharmaceutical Drugs Market

  • 19.1. Malaysia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 19.2. Malaysia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

20. Singapore Pharmaceutical Drugs Market

  • 20.1. Singapore, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 20.2. Singapore, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

21. Philippines Pharmaceutical Drugs Market

  • 21.1. Philippines, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 21.2. Philippines, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

22. Hong kong Pharmaceutical Drugs Market

  • 22.1. Hong Kong, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 22.2. Hong Kong, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

23. New Zealand Pharmaceutical Drugs Market

  • 23.1. New Zealand, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 23.2. New Zealand, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

24. Western Europe Pharmaceutical Drugs Market

  • 24.1. Western Europe Pharmaceutical Drugs Market Overview
  • 24.2. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. Western Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. Western Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. UK Pharmaceutical Drugs Market

  • 25.1. UK Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.2. UK Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. UK Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. Germany Pharmaceutical Drugs Market

  • 26.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.2. Germany Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. Germany Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. France Pharmaceutical Drugs Market

  • 27.1. France Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. France Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. France Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Italy Pharmaceutical Drugs Market

  • 28.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.2. Italy Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Italy Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Spain Pharmaceutical Drugs Market

  • 29.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.2. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Austria Pharmaceutical Drugs Market

  • 30.1. Austria, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 30.2. Austria, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

31. Belgium Pharmaceutical Drugs Market

  • 31.1. Belgium, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 31.2. Belgium, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

32. Denmark Pharmaceutical Drugs Market

  • 32.1. Denmark, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 32.2. Denmark, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

33. Finland Pharmaceutical Drugs Market

  • 33.1. Finland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 33.2. Finland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

34. Ireland Pharmaceutical Drugs Market

  • 34.1. Ireland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 34.2. Ireland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

35. Netherlands Pharmaceutical Drugs Market

  • 35.1. Netherlands, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 35.2. Netherlands, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

36. Norway Pharmaceutical Drugs Market

  • 36.1. Norway, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 36.2. Norway, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

37. Portugal Pharmaceutical Drugs Market

  • 37.1. Portugal, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 37.2. Portugal, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

38. Sweden Pharmaceutical Drugs Market

  • 38.1. Sweden, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 38.2. Sweden, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

39. Switzerland Pharmaceutical Drugs Market

  • 39.1. Switzerland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 39.2. Switzerland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

40. Eastern Europe Pharmaceutical Drugs Market

  • 40.1. Eastern Europe Pharmaceutical Drugs Market Overview
  • 40.2. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 40.3. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 40.4. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

41. Russia Pharmaceutical Drugs Market

  • 41.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 41.2. Russia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 41.3. Russia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

42. Czech Republic Pharmaceutical Drugs Market

  • 42.1. Czech Republic, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 42.2. Czech Republic, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

43. Poland Pharmaceutical Drugs Market

  • 43.1. Poland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 43.2. Poland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

44. Romania Pharmaceutical Drugs Market

  • 44.1. Romania, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 44.2. Romania, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

45. Ukraine Pharmaceutical Drugs Market

  • 45.1. Ukraine, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 45.2. Ukraine, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

46. North America Pharmaceutical Drugs Market

  • 46.1. North America Pharmaceutical Drugs Market Overview
  • 46.2. North America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 46.3. North America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 46.4. North America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

47. USA Pharmaceutical Drugs Market

  • 47.1. USA Pharmaceutical Drugs Market Overview
  • 47.2. USA Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 47.3. USA Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 47.4. USA Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

48. Canada Pharmaceutical Drugs Market

  • 48.1. Canada Pharmaceutical Drugs Market Overview
  • 48.2. Canada Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 48.3. Canada Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 48.4. Canada Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

49. Mexico Pharmaceutical Drugs Market

  • 49.1. Mexico, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 49.2. Mexico, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

50. South America Pharmaceutical Drugs Market

  • 50.1. South America Pharmaceutical Drugs Market Overview
  • 50.2. South America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 50.3. South America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 50.4. South America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

51. Brazil Pharmaceutical Drugs Market

  • 51.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 51.2. Brazil Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 51.3. Brazil Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

52. Chile Pharmaceutical Drugs Market

  • 52.1. Chile, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 52.2. Chile, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

53. Argentina Pharmaceutical Drugs Market

  • 53.1. Argentina, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 53.2. Argentina, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

54. Colombia Pharmaceutical Drugs Market

  • 54.1. Colombia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 54.2. Colombia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

55. Peru Pharmaceutical Drugs Market

  • 55.1. Peru, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 55.2. Peru, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

56. Middle East Pharmaceutical Drugs Market

  • 56.1. Middle East Pharmaceutical Drugs Market Overview
  • 56.2. Middle East Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 56.3. Middle East Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 56.4. Middle East Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

57. Saudi Arabia Pharmaceutical Drugs Market

  • 57.1. Saudi Arabia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 57.2. Saudi Arabia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

58. Israel Pharmaceutical Drugs Market

  • 58.1. Israel, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 58.2. Israel, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

59. Iran Pharmaceutical Drugs Market

  • 59.1. Iran, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 59.2. Iran, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

60. Turkey Pharmaceutical Drugs Market

  • 60.1. Turkey, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 60.2. Turkey, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

61. United Arab Emirates Pharmaceutical Drugs Market

  • 61.1. United Arab Emirates, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 61.2. United Arab Emirates, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

62. Africa Pharmaceutical Drugs Market

  • 62.1. Africa Pharmaceutical Drugs Market Overview
  • 62.2. Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 62.3. Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 62.4. Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

63. Egypt Pharmaceutical Drugs Market

  • 63.1. Egypt, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 63.2. Egypt, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

64. Nigeria Pharmaceutical Drugs Market

  • 64.1. Nigeria, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 64.2. Nigeria, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

65. South Africa Pharmaceutical Drugs Market

  • 65.1. South Africa, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 65.2. South Africa, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

66. Pharmaceutical Drugs Market Competitive Landscape And Company Profiles

  • 66.1. Pharmaceutical Drugs Market Competitive Landscape
  • 66.2. Pharmaceutical Drugs Market Company Profiles
    • 66.2.1. Pfizer Inc.
      • 66.2.1.1. Overview
      • 66.2.1.2. Products and Services
      • 66.2.1.3. Strategy
      • 66.2.1.4. Financial Performance
    • 66.2.2. AbbVie
      • 66.2.2.1. Overview
      • 66.2.2.2. Products and Services
      • 66.2.2.3. Strategy
      • 66.2.2.4. Financial Performance
    • 66.2.3. Johnson & Johnson
      • 66.2.3.1. Overview
      • 66.2.3.2. Products and Services
      • 66.2.3.3. Strategy
      • 66.2.3.4. Financial Performance
    • 66.2.4. Merck & Co
      • 66.2.4.1. Overview
      • 66.2.4.2. Products and Services
      • 66.2.4.3. Strategy
      • 66.2.4.4. Financial Performance
    • 66.2.5. Sanofi S.A.
      • 66.2.5.1. Overview
      • 66.2.5.2. Products and Services
      • 66.2.5.3. Strategy
      • 66.2.5.4. Financial Performance

67. Pharmaceutical Drugs Market Other Major And Innovative Companies

  • 67.1. F. Hoffmann-La Roche Ltd.
  • 67.2. Novartis AG
  • 67.3. Bristol-Myers Squibb
  • 67.4. AstraZeneca
  • 67.5. GlaxosmithKline
  • 67.6. Shanghai Pharmaceutical Drugs
  • 67.7. Shanghai Fosun Pharmaceutical
  • 67.8. Takeda Pharmaceutical Company Ltd.
  • 67.9. Otsuka Pharmaceutical Co. Ltd.
  • 67.10. Daiichi Sankyo
  • 67.11. China National Pharmaceutical Group Co., Ltd. (Sinopharm)
  • 67.12. Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • 67.13. Jiangsu Hengrui Medicine Co., Ltd
  • 67.14. Hanmi Pharmaceutical
  • 67.15. Cipla Limited

68. Global Pharmaceutical Drugs Market Competitive Benchmarking

69. Global Pharmaceutical Drugs Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

71. Pharmaceutical Drugs Market Future Outlook and Potential Analysis

  • 71.1 Pharmaceutical Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 71.2 Pharmaceutical Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 71.3 Pharmaceutical Drugs Market In 2028 - Growth Strategies
    • 71.3.1 Market Trend Based Strategies
    • 71.3.2 Competitor Strategies

72. Appendix

  • 72.1. Abbreviations
  • 72.2. Currencies
  • 72.3. Historic And Forecast Inflation Rates
  • 72.4. Research Inquiries
  • 72.5. The Business Research Company
  • 72.6. Copyright And Disclaimer
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제